Status | Study |
Suspended |
Study Name: Dabrafenib and Trametinib in People With BRAF V600E Mutation Positive Lesions in Erdheim Chester Disease Condition: BRAF V600E Mutation Date: 2014-11-01 Interventions: Drug: Dabrafenib Mesylate Desc |
Recruiting |
Study Name: LCH-IV, International Collaborative Treatment Protocol for Children and Adolescents With Langerhans Cell Histiocytosis Condition: Langerhans Cell Histiocytosis Date: 2014-07-07 Interventions: Drug: Prednisone Stratum I |
Withdrawn |
Study Name: Clofarabine for Langerhans in Pedi Condition: Langerhans Cell Histiocytosis Date: 2013-02-19 Interventions: Drug: Clofarabine |
Completed |
Study Name: Evaluation of Outcome of Adult Pulmonary Langerhans Cell Histiocytosis Based on Lung HRCT and Lung Function Condition: Pulmonary Langerhans Cell Histiocytosis Date: 2012-07-25 |
Active, not recruiting |
Study Name: Evaluation of Efficacy and Tolerance of Cladribine in Symptomatic Pulmonary Langerhans Cell Histiocytosis Condition: Langerhans Cell Histiocytosis of Lung Date: 2011-10-14 Interventions: Drug: Cladribine Subcutaneous injections, 0,1 mg/kg/day for 5 days, one course per month for 4 months |
Recruiting |
Study Name: A Study to Test the Ability of and Safety of GSK2110183 in Treating Langerhans Cell Histiocytosis Condition: Langerhans Cell Histiocytosis Date: 2011-07-12 Interventions: Drug: GSK2110183 Drug will be administered as 125 mg capsules once daily. |
Completed |
Study Name: Ceftriaxone in Non-neutropenic Fever Condition: Histiocytosis Pediatric Patients With Cancer Date: 2010-10-15 |
Completed |
Study Name: Prospective Evaluation of Adult Pulmonary Langerhans Cell Histiocytosis Condition: Adult Pulmonary Langerhans Cell Histiocytosis Date: 2010-10-12 Interventions: Behavioral: Tabacco discontinuation Tabacco discontinuation |
Terminated |
Study Name: Unrelated Donor Transplant for Malignant and Non-Malignant Disorders Condition: Leukemia Lymphoma Bone Marrow Failure Syndromes Date: 2008-06-03 Interventions: Procedure: UDAlloSCT unrelated |
Terminated |
Study Name: Reduced Intensity Hematopoietic Cell Transplantation for Patients With Resistant Langerhans Cell Histiocytosis Condition: Histiocytosis, Langerhans-cell Date: 2008-02-19 Interventions: Biological: alemtuzumab Admini |